CNMD

CONMED Corp

NYSE· Electromedical & Electrotherapeutic Apparatus· Inc. DE· CIK 0000816956 Healthcare & Medical Devices

$47.20 −0.48 (−1.01%)

Oct 27 4:00 PM ET · prev $47.68

Market cap

$1.5B

Small cap

Consensus

Hold

0% Buy or better · 12 analysts

Median target

$45.00

−5% · range $43.00–49.00

1 year

−0.3%

from $47.32 · Oct 28

30 days

+1.5%

from $46.48

52-week range

$32.11–51.86

−9% from high · low Jun 17

Avg volume 20D

402.7K

shares / day

Short interest

1.91M

≈6.4% of shares · −2.2%

Days to cover

4.7

at average volume

Insider net

no open-market trades · 12 mo

New fund stakes

Q2 2026 13F · 1 exit

Filing reports

analyzed by SecBot

SecBot read MIXED 4 reports · latest

Balance 0 bearish · 0 bullish · 1 mixed · 3 neutral oldest → newest, height = score

Avg score

·High conf. 4/4

Strongest MIXED CONMED entered into a $450 million incremental senior secured delayed draw term loan facility (Term A-2) to…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

R Jun 1 CONMED entered into a $450 million incremental senior secured delaye…
A Jun 29 B of A Securities downgrades
A Jul 9 BMO Capital initiates

Signal stack

Where each data set points today.

InsidersNO TRADES

No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
InstitutionsBULLISH

Q2 2026: 22 added (0 new), 13 trimmed or exited.
AnalystsMIXED

0 of 12 rate it Buy or better. Median target $45.00 (−5%).
Short sellersSTEADY

Short interest −2.2% to 1.91M shares. 4.7 days to cover, ≈6.4% of shares.
TrendRANGE

0% below its 50-day average.

Who's buying

13F· Q2 2026

new positions

exit

Fund	Move	Shares	Value
SILVERCREST ASSET MANAGEMENT GROUP LLC	TRIM	441,361	$14.4M
VICTORY CAPITAL MANAGEMENT INC	DOUBLED	229,622	$7.5M
NORDEA INVESTMENT MANAGEMENT AB	DOUBLED	205,273	$6.7M
CITADEL ADVISORS LLC	TRIM	142,263	$4.7M
JANE STREET GROUP, LLC	ADD	124,476	$4.1M
MILLENNIUM MANAGEMENT LLC	ADD	114,609	$3.8M
Jefferies Financial Group Inc.	DOUBLED	114,308	$3.7M
FIRST TRUST ADVISORS LP	ADD	111,056	$3.6M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

12 analysts

Hold 0% rate it Buy or better

Strong Buy0Buy0Hold8Sell2Strong Sell2

12-month targets · 6 analysts

$47.20 $43.00 $45.00 $49.00

Price is inside the target range. Median implies −5%.Targets as of Oct 28, 2026.

Recent actions

Date	Firm	Action	Rating
Jul 30, 2026	Piper Sandler REITERATE	REITERATE	Neutral
Jul 30, 2026	Wells Fargo MAINTAIN	MAINTAIN	Equal-Weight
Jul 9, 2026	BMO Capital INITIATE	INITIATE	Market Perform
Jun 29, 2026	B of A Securities DOWNGRADE	DOWNGRADE	Underperform
May 18, 2026	B of A Securities MAINTAIN	MAINTAIN	Neutral
May 1, 2026	Wells Fargo MAINTAIN	MAINTAIN	Equal-Weight

Insider ledger

Form 4

open-market buys or sells · 12 mo

Date	Insider	Type	Value
Sep 8, 2026	Kelderman Kim Director	EXERCISE	500 sh
Jul 15, 2026	Gallagher John E Executive Vice President & CFO	AWARD	35,054 sh
Jul 15, 2026	Gallagher John E Executive Vice President & CFO	AWARD	26,875 sh
Jul 15, 2026	Gallagher John E Executive Vice President & CFO	AWARD	30,536 sh
Jul 1, 2026	Mirviss Jeffrey B. Director	AWARD	5,603 sh
Jul 1, 2026	Martin Celine Christine Director	AWARD	5,603 sh
Jun 2, 2026	Schwarzentraub Barbara J Director	EXERCISE	668 sh
Jun 2, 2026	Kaye Mark Director	EXERCISE	668 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

Period	EPS est.	Range	30D rev.	Revenue
Current Q	🔒 Fresh data, subscribers only
Next Q	$1.27	$1.24–$1.28	+0.0%	$369.0M
Current FY	🔒 Fresh data, subscribers only
Next FY	🔒 Fresh data, subscribers only